Pregnolia, an ETH Spin-off founded in 2016, is dedicated to enhancing pregnancy care with their innovative device. Driven by the groundbreaking Ph. D.

Sabrina Badir, the team at Pregnolia focuses on studying changes in the stiffness of the human uterine cervix during pregnancy. By detecting these changes earlier and more accurately, they aim to assess the risk of preterm birth more effectively. With a collaborative approach, the growing team combines scientific, technical, and medical expertise to develop their groundbreaking products.

Ensuring top-notch quality, Pregnolia has implemented a quality management system in accordance with the recognized standard EN ISO 13485:2016. This certification demonstrates their compliance with the requirements for designing and manufacturing medical devices. Furthermore, their products are CE certified and meet the standards of the EU Directive 93/42/EEC on Medical Devices.

Please note that Pregnolia products are currently available for sale in selected markets in Europe. Visit their website for an insight into their privacy policy, terms and conditions, as well as their comprehensive range of offerings